ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

31
Analysis
Health CareAustralia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
bullishProbiotec Ltd
27 Mar 2024 21:46

Probiotec (PBP AU): Scheme Vote on 29 May as Doubts on Pyridam’s Funding Linger

The spread reflects concerns about the credibility of Pyridam’s funding (which requires OJK approval) due to the stark disparities in market cap....

Logo
391 Views
Share
30 Oct 2023 17:30

Dr. Reddy's Laboratories (DRRD IN): Highest Ever Sales and Profit in Q2; Good Show in Key Markets

Revenue increased 9% YoY to INR69B, beating street’s expectation of INRINR68, driven by double-digit growth North America and Europe. Net profit...

Logo
327 Views
Share
bullishMayne Pharma
19 Aug 2023 17:16

Mayne Pharma (MYX AU): Sale of Retail Generic Portfolio Shifts Focus on US Women’s Health and Derma

Mayne Pharma’s all three continuing businesses are now generating positive contribution margins. The company is expected to cut net loss...

Logo
445 Views
Share
17 Aug 2023 06:04

S&P/​​​​​​​​​ASX Index Rebalance Preview: Potential Adds Have Outperformed

We forecast 26 changes across the ASX50, ASX100, ASX 200 and ASX300 indices at the September rebalance. There is big flow and impact on a lot of...

Logo
551 Views
Share
28 Jul 2023 18:38

Dr. Reddy's Laboratories (DRRD IN): Q1FY24 Result- US Business Shines; PAT Jumps 18%

North America sales grew 79% y/y and 26% q/q to INR32 billion, driven by new product launches, continued momentum in existing products, favorable...

Logo
380 Views
Share
x